肿瘤学创新（英文）2025，Vol.4Issue(5)：92-96,5.DOI:10.1002/cai2.70029
Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia:A Case Report
Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia:A Case Report
Mengyuan Li 1Mao Ding 1Yukun Hou 1Xuening Duan 1Yuanjia Cheng 1Ling Xu1
作者信息
- 1. Department of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,China
- 折叠
摘要
关键词
breast cancer/HER2-low/microangiopathic hemolytic anemia/trastuzumab deruxtecanKey words
breast cancer/HER2-low/microangiopathic hemolytic anemia/trastuzumab deruxtecan引用本文复制引用
Mengyuan Li,Mao Ding,Yukun Hou,Xuening Duan,Yuanjia Cheng,Ling Xu..Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia:A Case Report[J].肿瘤学创新（英文）,2025,4(5):92-96,5.
